• Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=19593635).
  
• Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (PubMed=19593635).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=28889351; ATCC=HTB-132).
  

Moore G.E., Ito E., Ulrich K., Sandberg A.A.
Culture of human leukemia cells.
Cancer 19:713-723(1966)

Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: cellular studies and carrier identification.
Pediatr. Res. 9:475-480(1975)

Cancer Res. 37:2918-2929(1977)

Rae P.A., Yip C.C., Schimmer B.P.
Isolation of cloned Syrian hamster insulinoma cell lines with limited capacity for insulin production.
Can. J. Physiol. Pharmacol. 57:819-824(1979)

Respiration-deficient Chinese hamster cell mutants: genetic characterization.
Somatic Cell Genet. 5:225-240(1979)

Can. J. Fish. Aquat. Sci. 37:1070-1075(1980)

Proc. Natl. Acad. Sci. U.S.A. 77:4113-4117(1980)

ovary cell.
Somatic Cell Genet. 9:165-173(1983)

Hill S.M., Rodgers C.S., Hulten M.A., Wilson A.P.
Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma.
Cancer Genet. Cytogenet. 12:321-327(1984)

Characterization of three human malignant mesothelioma cell lines.
Cancer Genet. Cytogenet. 42:115-128(1989)

Oncogene 6:2033-2040(1991)

Epstein-Barr virus DNA recombines via latent origin of replication with the human genome in the lymphoblastoid cell line RGN1.
J. Virol. 66:5677-5681(1992)

Gazdar A.F., Minna J.D.
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.
Oncogene 7:339-346(1992)

sarco/endoplasmic reticulum Ca2+ transport ATPase in thapsigargin-resistant hamster smooth muscle cells.
Nucleic Acids Res. 26:4529-4537(1998)

Zheng J.L., Lewis A.K., Gao W.-Q.
Establishment of conditionally immortalized rat utricular epithelial cell lines using a retrovirus-mediated gene transfer technique.
Hear. Res. 117:13-23(1998)

Osborne B.
Characterization of a mutant T-cell hybridoma line with defects in the TCR-mediated apoptotic pathway.
Cell Death Differ. 6:36-47(1999)

Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
Haematologica 85:496-501(2000)

Mol. Cell. Biol. 24:2842-2852(2004)

Stojkoski A., Glorion C., Jaubert F.
DOR-1, A novel CD10+ stromal cell line derived from progressive Langerhans cell histiocytosis of bone.
Pediatr. Blood Cancer 44:128-137(2005)

squamous cell carcinoma.
Cancer Sci. 97:1351-1358(2006)

Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W.-W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F.-T., Zhang J.-J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E.
Global variation in copy number in the human genome.
Nature 444:444-454(2006)

Taylor D.D., Gercel-Taylor C.
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Gynecol. Oncol. 110:13-21(2008)

Chen W.-B., Xie M., Wang W.-L., Hammond S., Andersen M.R., Neff N., Passarelli B., Koh W., Fan H.C., Wang J.-B., Gui Y.-T., Lee K.H., Betenbaugh M.J., Quake S.R., Famili I., Palsson B.O., Wang J.
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line.
Nat. Biotechnol. 29:735-741(2011)

Elia G., Marincola F.M., McCubrey J.A., Libra M., Travali S., Kane M.
Characterization of human melanoma cell lines and melanocytes by proteome analysis.
Cell Cycle 10:2924-2936(2011)

Immunopurification of adenomatous polyposis coli (APC) proteins.
BMC Res. Notes 6:429.1-429.8(2013)

Maruyama K., Hori O., Hibino S., Choshi T., Nakahata T., Hioki H., Kaneko T., Naitoh M., Yoshikawa K., Yamawaki S., Suzuki S., Hata R., Ueno S.-i., Seki T., Kobayashi K., Toda T., Murakami K., Irie K., Klein W.L., Mori H., Asada T., Takahashi R., Iwata N., Yamanaka S., Inoue H.
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness.
Cell Stem Cell 12:487-496(2013)

Kosaka A., Ohkuri T., Okada H.
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells.
Cancer Immunol. Immunother. 63:847-857(2014)

juveniles.
Bull. Eur. Assoc. Fish Pathol. 36:155-163(2016)

Tumour resistance in induced pluripotent stem cells derived from naked mole-rats.
Nat. Commun. 7:11471.1-11471.9(2016)

modeling.
Stem Cell Res. 23:73-76(2017)

Robison R.A., O'Neill K.L.
Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane.
Onco Targets Ther. 10:1921-1932(2017)

Baryshnikova M.A.
Characteristics of Mel Ibr melanoma line subclone after treatment with chicken embryo extract.
Bull. Exp. Biol. Med. 163:255-259(2017)

Cancer Sci. 109:3171-3182(2018)

evaluating anti-cancer drug resistant cell lines.
BMC Cancer 21:1049.1-1049.13(2021)

Correction to: Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.
Cancer Chemother. Pharmacol. 88:1055-1056(2021)